Lyra Therapeutics, Inc. (LYRA)

CIK 1327273 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Lyra Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
May 15, 202640001193125-26-227500
Apr 30, 202615-12G0001193125-26-194908
Apr 20, 2026250001193125-26-164179
Apr 17, 20268-K0001193125-26-160421
Apr 10, 20268-K0001193125-26-150441
Apr 3, 202640001193125-26-142100
Apr 3, 202640001193125-26-142099
Mar 31, 202610-K0001327273-26-000003
Mar 26, 2026S-8 POS0001193125-26-124494
Mar 26, 2026EFFECT9999999995-26-000936
Mar 26, 2026POS AM0001193125-26-124474
Mar 26, 2026S-8 POS0001193125-26-124484
Mar 26, 2026S-8 POS0001193125-26-124489
Mar 26, 2026S-8 POS0001193125-26-124490
Mar 26, 2026EFFECT9999999995-26-000934
Mar 26, 2026S-8 POS0001193125-26-124492
Mar 26, 2026POS AM0001193125-26-124477
Mar 26, 2026EFFECT9999999995-26-000939
Mar 26, 2026POS AM0001193125-26-124481
Mar 16, 20268-K0001193125-26-108439
Feb 27, 20268-K0001193125-26-083251
Feb 6, 20268-K0001193125-26-041191
Jan 27, 20261440001959173-26-000457
Jan 20, 2026SCHEDULE 13G0001535610-26-000011
Jan 12, 20268-K0001193125-26-009772